U.S. Challenges in EV Battery Production

By Amanda Mayoral   The U.S. is lagging behind China and the European Union in production of lithium-ion batteries for electric vehicles. Forecasts show the U.S. will fall further behind China by 2025 and remain dependent on imports for more than half of its EV battery needs. This CPA Policy Paper by CPA Economist Amanda…

Tariffs Could Have Helped Us Avoid the Current Inflation Spike

  By Amanda Mayoral   Summary Global supply-chain crises, over-dependence on foreign production and government stimulus best explain the current inflation problem. Policy makers should learn from current crises and enact policies to reduce our strong dependence on unreliable foreign suppliers. Tariffs can cause a one-time rise in prices, but they don’t cause persistent month-after-month…

CPA Joins USTR, Pro-Worker Groups in Opposing Toomey “Poison Pill” to Gut Sec. 301 China Tariffs

WASHINGTON — The Coalition for a Prosperous America (CPA) today released a statement opposing Senator Pat Toomey’s (R-PA) poison pill effort to gut Section 301 of the Trade Act of 1974 and undermine efforts to address unfair foreign trade practices by China. Specifically, CPA is urging Senators to oppose the Toomey motion to instruct (MTI)…

Should the Renaissance in American Manufacturing be a Top-Down or Bottom-Up Approach? Perhaps the Answer is Both

By: Greg Owens, Co-Founder and CEO, Sherrill Manufacturing Inc. We have entered a new post-pandemic phase in world economic order.  Deglobalization is now upon us.  It started with a relatively “slow impact” move to decouple from China.  This was characterized by diplomacy followed by limited and low-percentage tariffs on certain Chinese goods.  Two years of…

CPA Launches Americans for Safe Drugs

Fighting Against Chinese & Indian Generic Pharmaceutical Manufacturers Exporting Unsafe Products to the U.S. WASHINGTON — The Coalition for a Prosperous America (CPA) today announced the launch of Americans for Safe Drugs©, a new campaign fighting against foreign generic pharmaceutical manufacturers in China and India that are flagrantly violating the Food and Drug Administration’s (FDA)…